Cite
HARVARD Citation
Weigert, G. et al. (2008). Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. British journal of ophthalmology. 92 (3), pp. 356-360. [Online].